No Prescription

Alpha Index V

No Prescription » Products » Alpha Index V

List of Drugs:

A  B  C  D  E  F  G  H  I  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Z  #

Products V:

Vagifem Vaginal Generic 17 oestradiol

Vagisil Freshday wipes

Vagisil Powder

Vagisil wash

VALCIVIR Valtrex

Vallergan Forte Syrup Generic Trimeprazine Tartarate

Valparin (Valproic Acid)

Valsartan

Valtan Diovan

Valtrex (Valacyclovir)

VALZAAR 80 H Generic Valsartan

VALZAAR Starval

Vantin (Cefpodoxime)

Vasotec (Enalapril)

Vectavir Cream Denavir

Veekend Cialis

Venlift OD Effexor XR

VENLOR Effexor XR

VENTOLIN INHALER Ventorlin

Ventorlin CFC Free Inhaler Proventil

VERADANAFIL Levitra

Vergo Generic Betahistine

Vermazol Vermox

Vermox Generic Mebendazole

Verpamil Calan

Verpamil SR Calan SR

VERTIN Serc

Viagra Revatio

Vicrom 5 Tilade

Videx (Didanosine)

Vigamox Generic Moxifloxacin

Viraday Atripla

VIRAMUNE Generic Nevirapine

Viread (Tenofovir)

Virenza with Revolizer Relenza

Virility Pills

Virosil Asiviral

Vitadol C Ascorbic acid

Vitamax Fish Oil

Vitamax Glucosamine Generic Glucosamine HCL

Vitamax Joint Mobility Generic Glucosamine Chondroitin

Vitamax Multivitamin Minerals Centrum

Vitamax Vitamin C

Vitamin A Protective Ointment

Vitamin B Complex

Vivatinell Acnecinamide Acne scrub

Volmax

Volmax Generic Salbutamol

Voltaren Cataflam

Voltaren (Diclofenac)

Voltaren Emulgel Generic Diclofenac

Voltaren Rapid Voveran

Voltaren SR Cataflam

Voritek Vfend

VOVERAN EMUGEL Voltaren

Voveran SR Voltaren SR

VOVERAN Voltaren

Previous  Next

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.